Evidence map›Paper›PMID 37640922›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2023

Delayed estrogen actions diminish food consumption without changing food approach, motor activity, or hypothalamic activation elicited by corticostriatal µ-opioid signaling.

Julio C Diaz, Kate Dunaway, Carla Zuniga, Elizabeth Sheil, Ken Sadeghian, Anthony P Auger, Brian A Baldo

Open access · greenAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Julio C DiazNeuroscience Training Program, University of Wisconsin-Madison, Madison, WI, USA.
Kate DunawayDepartment of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA.
Carla ZunigaDepartment of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA.
Elizabeth SheilCollege of Letters and Science, University of Wisconsin-Madison, Madison, WI, USA.
Ken SadeghianDepartment of Psychiatry, University of Wisconsin-Madison, Madison, WI, USA.
Anthony P AugerNeuroscience Training Program, University of Wisconsin-Madison, Madison, WI, USA.
Brian A BaldoNeuroscience Training Program, University of Wisconsin-Madison, Madison, WI, USA. babaldo@wisc.edu.
University of Wisconsin–Madison · US

Funding

Prefrontal cortex-hypothalmus interactions and feedingR01MH074723 · NIMH · UNIVERSITY OF WISCONSIN-MADISON · PI BALDO, BRIAN A · 2007 to 2019
$3.4M
NIMH NIH HHS R01 MH074723
6 · The paper itself

Abstract

Mu-opioid receptor (μ-OR) signaling in forebrain sites including nucleus accumbens (Acb) and ventromedial prefrontal cortex (vmPFC) modulates reward-driven feeding and may play a role in the pathophysiology of disordered eating. In preclinical models, intra-Acb or intra-vmPFC μ-OR stimulation causes overeating and vigorous responding for food rewards. These effects have been studied mainly in male animals, despite demonstrated sex differences and estrogen modulation of central reward systems. Hence, the present study investigated sex differences and estrogen modulation of intra-Acb and intra-vmPFC μ-OR-driven feeding behaviors. First, the dose-related effects of intra-Acb and intra-vmPFC infusions of the μ-OR-selective agonist, DAMGO, were compared among intact female, ovariectomized (OVX) female, and intact male rats. The DAMGO feeding dose-effect function was flattened in intact females relative to the robust, dose-dependent effects observed in OVX females and intact males. Thus, in intact females, intra-Acb DAMGO failed to elevate food intake relative to vehicle, while intra-vmPFC DAMGO elevated food intake, but to a smaller degree compared to males and OVX females. Next, to explore the possible role of estrogen in mediating the diminished DAMGO response observed in intact females, OVX rats were given intra-Acb or intra-vmPFC infusions of DAMGO either immediately after a subcutaneous injection of 17-beta-estradiol 3-benzoate (EB; 5 μg/0.1 mL) or 24 h after EB injection. Intra-Acb DAMGO effects were not changed at the immediate post-EB time point. At the delayed post-EB timepoint, significant lordosis was noted and the duration of intra-Acb DAMGO-driven feeding bouts was significantly reduced, with no change in the number of bouts initiated, locomotor hyperactivity, or Fos immunoreactivity in hypothalamic feeding and arousal systems. Similarly, EB failed to alter the motor-activational effects of intra-vmPFC DAMGO while reducing feeding. These findings indicate that delayed, presumably genomically mediated estrogen actions modulate the μ-OR-generated motivational state by reducing consummatory activity while sparing goal-approach and general arousal/activity. The results additionally suggest that EB regulation of consummatory activity occurs outside of forebrain-μ-OR control of hypothalamic systems.

Indexed as

Analgesics, OpioidFeeding BehaviorAnimalsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-EstrogensFemaleMaleMotor ActivityNucleus AccumbensRatsRats, Sprague-DawleyReceptors, Opioid, muAnalgesics, OpioidEnkephalin, Ala(2)-MePhe(4)-Gly(5)-EstrogensReceptors, Opioid, mu

Identifiers

PMID37640922
PMCPMC10584984
OpenAlexW4386224990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.